Orphazyme to take part in panel discussion at the LifeSci Partners 10th Annual Healthcare Corporate Access Event

Orphazyme A/S
Investor news                                                                                                       


No. 01/2021                                                                                                          
Company Registration No. 32266355

Copenhagen, Denmark, January 4, 2021 – Orphazyme A/S (ORPHA.CO; ORPH), a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today announces Anders Vadsholt, Chief Financial Officer of Orphazyme, will take part in a panel discussion at the LifeSci Partners 10th Annual Healthcare Corporate Access Event, which is being held virtually from January 6-8 and 11-14, 2021.

The panel is titled “EU Companies IPO-ing in the US: Benefits of EU Companies Listing on NASDAQ” and takes place on Thursday, January 7, 2021 at 10:00 AM Eastern Standard Time. Investors can pre-register for the panel discussion here.

For additional information, please contact

Orphazyme A/S

Anders Vadsholt
Chief Financial Officer
+45 28 98 90 55
[email protected]

Investors, EU

LifeSci Advisors, LLC
Mary-Ann Chang
+44 7483 284 853
[email protected]
Investors, US

LifeSci Advisors, LLC
Ashley R. Robinson
+617 775 5956
[email protected]



About Orphazyme A/S 
Orphazyme is a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases. The company is harnessing amplification of Heat-Shock Proteins (or HSPs) to develop and commercialize novel therapeutics for diseases caused by protein misfolding, protein aggregation, and lysosomal dysfunction, including lysosomal storage diseases and neuromuscular degenerative diseases. Arimoclomol, the company’s lead candidate, is in clinical development for four orphan diseases: Niemann-Pick disease Type C (NPC), Amyotrophic Lateral Sclerosis (ALS), Inclusion Body Myositis (IBM) and Gaucher disease. Orphazyme is headquartered in Denmark and has operations in the U.S., Switzerland, France and Germany. Orphazyme’s shares are listed on Nasdaq U.S. (ORPH) and Nasdaq Copenhagen (ORPHA.CO). 


About arimoclomol 

Arimoclomol is an investigational drug candidate that amplifies the production of Heat-Shock Proteins (HSPs). HSPs can rescue defective misfolded proteins, clear protein aggregates, and improve the function of lysosomes. Arimoclomol is administered orally, crosses the blood-brain barrier, and has now been studied in seven phase 1, four phase 2 and one pivotal phase 2/3 trial. Arimoclomol is in clinical development for NPC, Gaucher Disease, IBM, and ALS. Arimoclomol has received orphan drug designation (ODD) for NPC, IBM, and ALS in the US and EU. Arimoclomol has received fast-track designation (FTD) from the U.S. Food and Drug Administration (FDA) for NPC, IBM and ALS. In addition, arimoclomol has received breakthrough therapy designation (BTD) and rare-pediatric disease designation (RPDD) from the FDA for NPC.

Forward-looking statement 
This company announcement may contain certain forward-looking statements. Although the Company believes its expectations are based on reasonable assumptions, all statements other than statements of historical fact included in this company announcement about future events are subject to (i) change without notice and (ii) factors beyond the Company’s control. These statements may include, without limitation, any statements preceded by, followed by, or including words such as “target,” “believe,” “expect,” “aim,” “intend,” “may,” “anticipate,” “estimate,” “plan,” “project,” “will,” “can have,” “likely,” “should,” “would,” “could”, and other words and terms of similar meaning or the negative thereof. Forward-looking statements are subject to inherent risks and uncertainties beyond the Company’s control that could cause the Company’s actual results, performance, or achievements to be materially different from the expected results, performance, or achievements expressed or implied by such forward-looking statements. Except as required by law, the Company assumes no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. 

Attachment



ADM Endeavors, Inc. (ADMQ) Announces Vice President of Marketing

–Significant Expertise in Revenue Generating Marketing Strategies–

FORT WORTH, TX, Jan. 04, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — ADM Endeavors, Inc. (OTCQB: ADMQ) is pleased to announce a recent addition to the Company staff. Subha Puthalath joined in January 2021 and brings significant experience in graphic design, social media, and marketing in print, e-mail and digital media. She will serve as the Company’s Vice President of Marketing in a full time, salaried position in the Fort Worth office.

“Subha brings to ADM Endeavors ten years of marketing experience helping customers create brands and brand awareness by implementing effective marketing strategies,” said Marc Johnson, ADMQ CEO. “She is an expert in managing and executing marketing campaigns from conception to completion using digital marketing platforms to increase sales and company productivity.”

“We very much are looking forward to our new VP of Marketing to develop revenue generating marketing strategies,” Mr. Johnson concluded.

Ms. Puthalath is a graduate in graphic design from the New York Institute of Art & Design. She also earned an MA in Economics from Calicut University, India. Her expertise includes digital photography, staging, product photography and web and logo design.

ABOUT ADMQ: Since 2010, our wholly owned subsidiary, Just Right Products, Inc., has been consistently profitable, with sales topping $3.8 million in 2019. The Company sells “Anything With A Logo” on its website, JustRightProducts.com, developing products ranging from unique business cards to coffee cups, T-shirts to boots, with tens of thousands of other unique products from which to select. The Company operates a diverse vertical integrated business in the Dallas/Fort Worth area, consisting of a retail sales division, screen print production, embroidery production, digital production, import wholesale sourcing, and uniforms.

Forward Looking Statement:

This press release contains certain “forward-looking statements,” as defined in the United States PSLRA of 1995, that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management’s current expectations. The economic, competitive, governmental, technological and other factors identified in the Company’s previous filings with the Securities and Exchange Commission may cause actual results or events to differ materially from those described in the forward-looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact: ADM Endeavors, Inc.

Paul Knopick 

[email protected]

940.262.3584



FCA announces conditional special cash distribution


IMPORTANT NOTICE


By reading the following communication, you agree to be bound by the following limitations and qualifications:

This communication is for informational purposes only and is not intended to and does not constitute an offer or invitation to exchange or sell or solicitation of an offer to subscribe for or buy, or an invitation to exchange, purchase or subscribe for, any securities, any part of the business or assets described herein, or any other interests or the solicitation of any vote or approval in any jurisdiction in connection with the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. This communication should not be construed in any manner as a recommendation to any reader of this document.

This communication is not a prospectus, product disclosure statement or other offering document for the purposes of Regulation (EU) 2017/1129 of the European Parliament and of the Council of June 14th 2017.

An offer of securities in the United States pursuant to a business combination transaction will only be made, as may be required, through a prospectus which is part of an effective registration statement filed with the U.S. Securities and Exchange Commission (“SEC”). Shareholders of Peugeot S.A. (“PSA”) and Fiat Chrysler Automobiles N.V. (“FCA”) who are U.S. persons or are located in the United States are advised to read the registration statement on Form F-4  which was declared effective by the SEC on November 20, 2020 because it contains important information relating to the proposed transaction. The registration statement on Form F-4 filed with the SEC on July 24, 2020, as amended, was declared effective on November 20, 2020. You may obtain copies of all documents filed with the SEC regarding the proposed transaction, documents incorporated by reference, and FCA’s SEC filings at the SEC’s website at http://www.sec.gov. In addition, the effective registration statement will be made available for free to shareholders in the United States.

FCA announces conditional special cash distribution

Fiat Chrysler Automobiles NV (NYSE: FCAU / MTA: FCA) announced today that its Board of Directors has declared a conditional special cash distribution of €1.84 per common share corresponding to a total distribution of approximately €2.9 billion (the “cash distribution”), payable to holders of FCA common shares of record as of the close of business on Friday, January 15, 2021.

FCA and Peugeot S.A. (“Groupe PSA”) announced today that they expect to complete their proposed merger on Saturday, January 16, 2021. Payment of the cash distribution is conditioned upon the further announcement that all required corporate steps in preparation for completion of the merger have been taken and that the cash distribution has become unconditional, which is expected to occur by Wednesday, January 13, 2021. Absent such announcement, no cash distribution will be payable.

If the cash distribution becomes unconditional as described above, the expected calendar for the cash distribution for both the New York Stock Exchange (“NYSE”) and the Mercato Telematico Azionario (“MTA”) will be as follows: (i) ex-date on Thursday, January 14, 2021; and (ii) record date on Friday, January 15, 2021. The cash distribution is expected to be paid as soon as practicable after the closing of the merger, and FCA will announce publicly the payment date in due course.

In order to ensure the coordination of the settlement on the NYSE and MTA of the cash distribution to be paid to FCA shareholders who are entitled thereto ahead of the merger, the ex-date and record date are expected to occur outside of Borsa Italiana’s usual settlement calendar, as agreed with Borsa Italiana.

While payment of the cash distribution will occur after closing of the merger, for the avoidance of doubt, no cash distribution will be payable with respect to shares of Stellantis issued to former shareholders of Groupe PSA upon effectiveness of the merger, or to any shareholder purchasing Stellantis shares after effectiveness of the merger.

London, January 4, 2021

For further information:
tel.: +39 (011) 00 31111
Email: [email protected]
www.fcagroup.com 

FORWARD-LOOKING STATEMENTS

This communication contains forward-looking statements. In particular, these forward-looking
statements include statements regarding future financial performance and the expectations of FCA and PSA (the “Parties”) as to the achievement of certain targeted metrics at any future date or for any future period are forward-looking statements. These statements may include terms such as “may”, “will”, “expect”, “could”, “should”, “intend”, “estimate”, “anticipate”, “believe”, “remain”, “on track”, “design”, “target”, “objective”, “goal”, “forecast”, “projection”, “outlook”, “prospects”, “plan”, or similar terms. Forward-looking statements are not guarantees of future performance. Rather, they are based on the Parties’ current state of knowledge, future expectations and projections about future events and are by their nature, subject to inherent risks and uncertainties. They relate to events and depend on circumstances that may or may not occur or exist in the future and, as such, undue reliance should not be placed on them.

Actual results may differ materially from those expressed in forward-looking statements as a result of a variety of factors, including: the impact of the COVID-19 pandemic, the ability of PSA and FCA and/or the combined group resulting from the proposed transaction (together with the Parties, the “Companies”) to launch new products successfully and to maintain vehicle shipment volumes; changes in the global financial markets, general economic environment and changes in demand for automotive products, which is subject to cyclicality; changes in local economic and political conditions, changes in trade policy and the imposition of global and regional tariffs or tariffs targeted to the automotive industry, the enactment of tax reforms or other changes in tax laws and regulations; the Companies’ ability to expand certain of their brands globally; the Companies’ ability to offer innovative, attractive products; the Companies’ ability to develop, manufacture and sell vehicles with advanced features including enhanced electrification, connectivity and autonomous-driving characteristics; various types of claims, lawsuits, governmental investigations and other contingencies, including product liability and warranty claims and environmental claims, investigations and lawsuits; material operating expenditures in relation to compliance with environmental, health and safety regulations; the intense level of competition in the automotive industry, which may increase due to consolidation; exposure to shortfalls in the funding of the Parties’ defined benefit pension plans; the ability to provide or arrange for access to adequate financing for dealers and retail customers and associated risks related to the establishment and operations of financial services companies; the ability to access funding to execute the Companies’ business plans and improve their businesses, financial condition and results of operations; a significant malfunction, disruption or security breach compromising information technology systems or the electronic control systems contained in the Companies’ vehicles; the Companies’ ability to realize anticipated benefits from joint venture arrangements; disruptions arising from political, social and economic instability; risks associated with our relationships with employees, dealers and suppliers; increases in costs, disruptions of supply or shortages of raw materials; developments in labor and industrial relations and developments in applicable labor laws; exchange rate fluctuations, interest rate changes, credit risk and other market risks; political and civil unrest; earthquakes or other disasters; uncertainties as to whether the proposed business combination discussed in this document will be consummated or as to the timing thereof; the risk that the announcement of the proposed business combination may make it more difficult for the Parties to establish or maintain relationships with their employees, suppliers and other business partners or governmental entities; the risk that the businesses of the Parties will be adversely impacted during the pendency of the proposed business combination; risks related to the regulatory approvals necessary for the combination; the risk that the operations of PSA and FCA will not be integrated successfully and other risks and uncertainties.

Any forward-looking statements contained in this communication speak only as of the date of this document and the Parties disclaim any obligation to update or revise publicly forward-looking statements. Further information concerning the Parties and their businesses, including factors that could materially affect the Parties’ financial results, are included in FCA’s reports and filings with the SEC (including the registration statement on Form F-4 filed with the SEC on July 24, 2020, as amended, which was declared effective on November 20,2020), the AFM and CONSOB and PSA’s filings with the AMF.

Attachment



Media Advisory – BMO CEO Darryl White to Speak at RBC Capital Markets Canadian Bank CEO Conference

Canada NewsWire

TORONTO, Jan. 4, 2021 /CNW/ – Darryl White, Chief Executive Officer of BMO Financial Group (TSX: BMO) (NYSE: BMO), will participate in the RBC Capital Markets Canadian Bank CEO Conference in Toronto on January 11, 2021 at 9:25AM ET.

Mr. White’s presentation will be broadcast live via webcast at https://www.bmo.com/home/about/banking/investor-relations/presentations-events/current. An archived version of the webcast will be available at the same location.

About BMO Financial Group

Serving customers for 200 years and counting, BMO is a highly diversified financial services provider – the 8th largest bank, by assets, in North America. With total assets of $949 billion as of October 31, 2020, and a team of diverse and highly engaged employees, BMO provides a broad range of personal and commercial banking, wealth management and investment banking products and services to more than 12 million customers and conducts business through three operating groups: Personal and Commercial Banking, BMO Wealth Management and BMO Capital Markets.

SOURCE BMO Financial Group

TMX Group, Revival Gold, C-Suite at The Open

Canada NewsWire

TORONTO, Jan. 4, 2021 /CNW/ – Hugh Agro, President & CEO, Revival Gold Inc. (TSXV: RVG), shares his company’s story in an interview with TMX Group.

The C-Suite at The Open video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange.  Videos provide insight into how company executives think in the current business environment.  To see the latest C-Suite at The Open videos visit https://www.tmxmoney.com/en/csuite.html.


About Revival Gold Inc. (TSXV: RVG)


Revival Gold Inc. is a growth-focused gold exploration and development company. It has executed an agreement whereby it may acquire a 100% interest in Meridian Beartrack Co., owner of Beartrack Gold Project located in Lemhi County, Idaho. Revival also owns rights to a 100% interest in the neighbouring Arnett Gold Gold Project. In addition to its interests in Beartrack and Arnett Gold, the company is pursuing other gold exploration and development opportunities and holds interest in the Diamond Mountain Phosphate Project located in Uintah County, Utah. For more information visit: http://www.revival-gold.com/ 


About TMX Group (TSX: X)

TMX Group’s key subsidiaries operate cash and derivative markets and clearinghouses for multiple asset classes including equities and fixed income. Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange, The Canadian Depository for Securities, Montréal Exchange, Canadian Derivatives Clearing Corporation, Trayport and other TMX Group companies provide listing markets, trading markets, clearing facilities, depository services, technology solutions, data products and other services to the global financial community. TMX Group is headquartered in Toronto and operates offices across North America (Montréal, Calgary, Vancouver and New York), as well as in key international markets including London, Beijing and Singapore. For more information about TMX Group, visit our website at www.tmx.com. Follow TMX Group on Twitter: @TMXGroup.

SOURCE TMX Group Limited

DLA Piper advises Seaspan Corporation in US$201.25 million 3.75% exchangeable senior notes offering

PR Newswire

NEW YORK, Jan. 4, 2021 /PRNewswire/ — DLA Piper represented Seaspan Corporation, a leading independent owner and operator of containerships, in its offering of US$201.25 million principal amount of 3.75% exchangeable senior notes due 2025 closed on December 21, 2020. The notes will be exchangeable under certain circumstances at the option of the holders into common shares of Seaspan’s parent, Atlas Corp. (NYSE: ATCO), cash, or a combination of Atlas shares and cash, at Seaspan’s election, unless the notes have been previously repurchased or redeemed. 

In connection with the offering, Seaspan entered into privately negotiated capped call transactions with certain financial institutions. The capped call transactions are expected generally to reduce the potential dilution to Atlas shares upon any exchange of notes and/or offset cash payments Seaspan is required to make upon exchange of the notes, in each case, subject to a cap.

“We were pleased to bring together a multi-disciplinary team with extensive experience advising clients in complex capital markets transactions to assist Seaspan in executing this offering, which will position it well for continued growth and success and provide capital to achieve its goals,” said Christopher Paci, chair of DLA Piper’s Capital Markets practice, who led the firm’s deal team along with partner Jamie Knox.

In addition to Paci and Knox (both of New York), the DLA Piper team representing Seaspan included partners Marc Horwitz (Chicago), Drew Young (New York), Ben Brown (London) and Anderson Lam (Hong Kong); and associates Arielle Katzman (New York), Drew Valentine (Austin/New York), Brendan Kelly (Baltimore) and John Wei (Boston).

DLA Piper’s global capital markets team represents issuers and underwriters in registered and unregistered  equity, equity-linked and debt capital markets transactions, including initial public offerings, follow-on equity offerings, equity-linked securities offerings, and offerings of investment grade and high-yield debt securities.

About DLA Piper

DLA Piper is a global law firm with lawyers located in more than 40 countries throughout the Americas, Europe, the Middle East, Africa and Asia Pacific, positioning us to help clients with their legal needs around the world. In certain jurisdictions, this information may be considered attorney advertising. dlapiper.com

Cision View original content:http://www.prnewswire.com/news-releases/dla-piper-advises-seaspan-corporation-in-us201-25-million-3-75-exchangeable-senior-notes-offering-301200289.html

SOURCE DLA Piper

Merger of FCA and Groupe PSA approved by shareholders: FCA and Groupe PSA expect to complete the combination on January 16, 2021



IMPORTANT NOTICE


By reading the following communication, you agree to be bound by the following limitations and qualifications:

This communication is for informational purposes only and is not intended to and does not constitute an offer or invitation to exchange or sell or solicitation of an offer to subscribe for or buy, or an invitation to exchange, purchase or subscribe for, any securities, any part of the business or assets described herein, or any other interests or the solicitation of any vote or approval in any jurisdiction in connection with the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. This communication should not be construed in any manner as a recommendation to any reader of this document.     

This communication is not a prospectus, product disclosure statement or other offering document for the purposes of Regulation (EU) 2017/1129 of the European Parliament and of the Council of June 14th 2017.

An offer of securities in the United States pursuant to a business combination transaction will only be made, as may be required, through a prospectus which is part of an effective registration statement filed with the U.S. Securities and Exchange Commission (“SEC”). Shareholders of Peugeot S.A. (“PSA”) and Fiat Chrysler Automobiles N.V. (“FCA”) who are U.S. persons or are located in the United States are advised to read the registration statement
on Form F-4  which was
declared effective by the SEC
on November 20, 2020
because it
contains
important information relating to the proposed transaction.
The
registration statement on Form F-4 filed with the SEC on July 24, 2020
, as amended, was
declared effective
on November 20, 2020.
You may obtain copies of all documents filed with the SEC regarding the proposed transaction, documents incorporated by reference, and FCA’s SEC filings at the SEC’s website at http://www.sec.gov. In addition, the effective registration statement will be made available for free to shareholders in the United States.

Vélizy-Villacoublay and London, January 4, 2021

Merger of FCA and Groupe PSA approved by shareholders: FCA and Groupe PSA expect to complete the combination on January 16, 2021

Fiat Chrysler Automobiles N.V. (“FCA”) (NYSE: FCAU / MTA: FCA) and Peugeot S.A. (“Groupe PSA”) announce that their respective shareholders’ meetings, held today, approved the merger of FCA and Groupe PSA to create Stellantis N.V. (“Stellantis”) by an overwhelming majority (with more than 99% of the votes cast in favor of the transaction). 

The shareholders of FCA also approved merger related matters, including adoption of the Stellantis’ Articles of Association and appointment of the previously announced members of the Board of Directors of Stellantis, in each case effective as of the date following completion of the merger. Details of the resolutions submitted to shareholders and voting results are available on the respective websites of FCA and Groupe PSA (www.fcagroup.com; www.groupe-psa.com).

Following today’s approval by shareholders and receipt of the final regulatory clearances over the course of the last month, including notably from the European Commission and the European Central Bank, FCA and Groupe PSA expect  to complete the combination on January 16, 2021.

Stellantis’ common shares will begin trading on the Mercato Telematico Azionario in Milan and Euronext in Paris on Monday, January 18, 2021, and on the New York Stock Exchange on Tuesday, January 19, 2021.

Investor Relations:

FCA                                                                            Groupe PSA

Joe Veltri: +1 248 576 9257                                     Andrea Bandinelli: + 33 6 82 58 86 04


[email protected]
                            [email protected]

For further information:

FCA

 

Groupe PSA
Andrea Pallard: +39 335 8737298

[email protected]

Shawn Morgan: +1 248 760 2621

[email protected]

Bertrand Blaise: +33 6 33 72 61 86

[email protected]

Pierre Olivier Salmon: +33 6 76 86 45 48

[email protected]

 


About FCA

Fiat Chrysler Automobiles (FCA) is a global automaker that designs, engineers, manufactures and sells vehicles in a portfolio of exciting brands, including Abarth, Alfa Romeo, Chrysler, Dodge, Fiat, Fiat Professional, Jeep®, Lancia, Ram and Maserati. It also sells parts and services under the Mopar name and operates in the components and production systems sectors under the Comau and Teksid brands. FCA employs nearly 200,000 people around the globe. For more information regarding FCA, please visit www.fcagroup.com


About Groupe PSA



Groupe PSA


designs unique automotive experiences and delivers mobility solutions to meet all customer expectations. The Group has five car brands, Peugeot, Citroën, DS, Opel and Vauxhall and provides a wide array of mobility and smart services under the Free2Move brand. Its ‘Push to Pass’ strategic plan represents a first step towards the achievement of the Group’s vision to be “a global carmaker with cutting-edge efficiency and a leading mobility provider sustaining lifetime customer relationships”. An early innovator in the field of autonomous and connected cars, Groupe PSA is also involved in financing activities through Banque PSA Finance and in automotive equipment via Faurecia.

Media library: medialibrary.groupe-psa.com
 
/       @GroupePSA_EN

FORWARD-LOOKING STATEMENTS

This communication contains forward-looking statements. In particular, these forward-looking statements include statements regarding future financial performance and the expectations of FCA and PSA (the “Parties”) as to the achievement of certain targeted metrics at any future date or for any future period are forward-looking statements. These statements may include terms such as “may”, “will”, “expect”, “could”, “should”, “intend”, “estimate”, “anticipate”, “believe”, “remain”, “on track”, “design”, “target”, “objective”, “goal”, “forecast”, “projection”, “outlook”, “prospects”, “plan”, or similar terms. Forward-looking statements are not guarantees of future performance. Rather, they are based on the Parties’ current state of knowledge, future expectations and projections about future events and are by their nature, subject to inherent risks and uncertainties. They relate to events and depend on circumstances that may or may not occur or exist in the future and, as such, undue reliance should not be placed on them.

Actual results may differ materially from those expressed in forward-looking statements as a result of a variety of factors, including: the impact of the COVID-19 pandemic, the ability of PSA and FCA and/or the combined group resulting from the proposed transaction (together with the Parties, the “Companies”) to launch new products successfully and to maintain vehicle shipment volumes; changes in the global financial markets, general economic environment and changes in demand for automotive products, which is subject to cyclicality; changes in local economic and political conditions, changes in trade policy and the imposition of global and regional tariffs or tariffs targeted to the automotive industry, the enactment of tax reforms or other changes in tax laws and regulations; the Companies’ ability to expand certain of their brands globally; the Companies’ ability to offer innovative, attractive products; the Companies’ ability to develop, manufacture and sell vehicles with advanced features including enhanced electrification, connectivity and autonomous-driving characteristics; various types of claims, lawsuits, governmental investigations and other contingencies, including product liability and warranty claims and environmental claims, investigations and lawsuits; material operating expenditures in relation to compliance with environmental, health and safety regulations; the intense level of competition in the automotive industry, which may increase due to consolidation; exposure to shortfalls in the funding of the Parties’ defined benefit pension plans; the ability to provide or arrange for access to adequate financing for dealers and retail customers and associated risks related to the establishment and operations of financial services companies; the ability to access funding to execute the Companies’ business plans and improve their businesses, financial condition and results of operations; a significant malfunction, disruption or security breach compromising information technology systems or the electronic control systems contained in the Companies’ vehicles; the Companies’ ability to realize anticipated benefits from joint venture arrangements; disruptions arising from political, social and economic instability; risks associated with our relationships with employees, dealers and suppliers; increases in costs, disruptions of supply or shortages of raw materials; developments in labor and industrial relations and developments in applicable labor laws; exchange rate fluctuations, interest rate changes, credit risk and other market risks; political and civil unrest; earthquakes or other disasters; uncertainties as to whether the proposed business combination discussed in this document will be consummated or as to the timing thereof; the risk that the announcement of the proposed business combination may make it more difficult for the Parties to establish or maintain relationships with their employees, suppliers and other business partners or governmental entities; the risk that the businesses of the Parties will be adversely impacted during the pendency of the proposed business combination; risks related to the regulatory approvals necessary for the combination; the risk that the operations of PSA and FCA will not be integrated successfully and other risks and uncertainties.

Any forward-looking statements contained in this communication speak only as of the date of this document and the Parties disclaim any obligation to update or revise publicly forward-looking statements. Further information concerning the Parties and their businesses, including factors that could materially affect the Parties’ financial results, are included in FCA’s reports and filings with the SEC (including the registration statement on Form F-4 filed with the SEC on July 24, 2020, as amended, which was declared effective on November 20,2020), the AFM and CONSOB and PSA’s filings with the AMF.

Attachment



Lowey Dannenberg, P.C. Shareholder Barbara Hart Resigns

NEW YORK, Jan. 04, 2021 (GLOBE NEWSWIRE) — Barbara Hart, a shareholder of Lowey Dannenberg, P.C. (“Lowey Dannenberg”), has resigned effective immediately. The Lowey Dannenberg family wishes Barbara well in her future endeavors. Vincent Briganti will remain as Chairman, and Lowey Dannenberg will continue to be managed by its Management Committee comprised of shareholders Gerald Lawrence, Peter St. Phillip, Geoffrey M. Horn and Mr. Briganti. 

Since the firm’s founding in the late 1960s by Stephen Lowey and Richard Dannenberg, Lowey Dannenberg has represented sophisticated clients in complex federal antitrust, commodities, and securities litigation. Lowey Dannenberg also regularly represents some of the world’s largest health insurers in healthcare cost recovery actions. The firm has more than 40 attorneys who specialize in prosecuting these cases.

Contact
Vincent Briganti
Chairman
Lowey Dannenberg. P.C.
914-733-7221



Fifth Third Completes Acquisition of Hammond Hanlon Camp LLC

Fifth Third Completes Acquisition of Hammond Hanlon Camp LLC

CINCINNATI–(BUSINESS WIRE)–
Fifth Third Bancorp (Nasdaq: FITB) announced that Fifth Third Acquisition Holdings, LLC has closed on the acquisition of Hammond Hanlon Camp LLC (“H2C”).

Founded in 2011, H2C is a premier strategic advisory and investment banking firm with an emphasis on healthcare organizations, including specialized expertise in the not-for-profit sector. Its core advisory services include mergers, acquisitions and divestitures, partnerships and strategic growth, capital markets and real estate investment banking.

The announcement underscores Fifth Third’s commitment to develop a robust, best-in-class healthcare platform and builds upon Fifth Third’s acquisition of Coker Capital in 2018. Over the last decade, the Bank’s healthcare team has expanded its breadth and expertise to become one of the top platforms to middle-market and corporate clients.

The signing of the acquisition was announced on Dec. 2, 2020 and the transaction became effective on Dec. 31, 2020. Alston & Bird LLP acted as legal advisor to Fifth Third. Houlihan Lokey acted as financial advisor and Winston & Strawn acted as legal advisor to H2C.

About Fifth Third

Fifth Third Bancorp is a diversified financial services company headquartered in Cincinnati, Ohio and the indirect parent company of Fifth Third Bank, National Association, a federally chartered institution. As of Sept. 30, 2020, Fifth Third had $202 billion in assets and operated 1,122 full-service banking centers and 2,414 ATMs with Fifth Third branding in Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, North Carolina and South Carolina. In total, Fifth Third provides its customers with access to approximately 52,000 fee-free ATMs across the United States. Fifth Third operates four main businesses: Commercial Banking, Branch Banking, Consumer Lending and Wealth & Asset Management. Fifth Third is among the largest money managers in the Midwest and, as of Sept. 30, 2020, had $422 billion in assets under care, of which it managed $53 billion for individuals, corporations and not-for-profit organizations through its Trust and Registered Investment Advisory businesses. Investor information and press releases can be viewed at www.53.com. Fifth Third’s common stock is traded on the Nasdaq® Global Select Market under the symbol “FITB.” Fifth Third Bank was established in 1858. Deposit and Credit products are offered by Fifth Third Bank, National Association. Member FDIC.

About Fifth Third Capital Markets

Fifth Third Capital Markets is the marketing name under which Fifth Third Bank, National Association, and its subsidiary, Fifth Third Securities, Inc., provide certain securities and investment banking products and services. Fifth Third Capital Markets offers investment banking++, debt capital markets+, bond capital markets++, equity capital markets++, financial risk management+, and fixed income sales and trading++. Fifth Third Bank, National Association, provides access to investments and investment services through various subsidiaries, including Fifth Third Securities. Coker Capital is a division of Fifth Third Securities. Fifth Third Securities is the trade name used by Fifth Third Securities, Inc., member FINRA / SIPC, a registered broker-dealer and registered investment advisor registered with the U.S. Securities and Exchange Commission (SEC). Registration does not imply a certain level of skill or training.

Securities and investments offered through Fifth Third Securities, Inc.:

Are Not FDIC Insured

Offer No Bank Guarantee

May Lose Value

Are Not Insured By Any Federal Government Agency

Are Not A Deposit

+ Services and activities offered through Fifth Third Bank, National Association.

About Hammond Hanlon Camp LLC (“H2C”)

Founded in 2011, H2C is an independent strategic advisory and investment banking firm committed to providing superior advice as a trusted advisor to healthcare organizations and related companies throughout the United States. H2C’s professionals have a long track record of success in healthcare mergers and acquisitions, capital markets, and real estate transactions, acting as lead advisors on hundreds of transactions representing billions of dollars in value. H2C offers securities through its wholly owned subsidiary H2C Securities Inc., member FINRA/SIPC. For more information, visit h2c.com.

Shandi Grant (MEDIA)

[email protected]

Chris Doll (INVESTORS)

[email protected]

KEYWORDS: Ohio United States North America

INDUSTRY KEYWORDS: General Health Finance Banking Health Professional Services

MEDIA:

Logo
Logo

Northwell Health Named Presenting Partner for New York Rangers Training Camp

Northwell Health Named Presenting Partner for New York Rangers Training Camp

Northwell Health Becomes the New York Rangers’ First Practice Jersey Sponsor

Rangers and Northwell Health Creating Year-Long Campaign to Celebrate

New Yorkers and Their Incredible Work in the Community

NEW YORK–(BUSINESS WIRE)–
The New York Rangers announced today that Northwell Health has been named the Presenting Partner for this year’s Rangers Training Camp, which includes becoming the New York Rangers’ first practice jersey sponsor. In addition, the Rangers and Northwell Health will partner on the “NYRises” campaign to pay homage to people around New York who have inspired their community during the most difficult times.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210104005153/en/

Northwell Health Becomes the New York Rangers' First Practice Jersey Sponsor (Photo: MSG Sports)

Northwell Health Becomes the New York Rangers’ First Practice Jersey Sponsor (Photo: MSG Sports)

As part of their jersey sponsorship, the Rangers and Northwell Health will identify several inspiring New Yorkers who will be given the opportunity to help design their own Rangers practice jersey. Rangers players will wear these jerseys periodically throughout the 2020-21 season. Each designer will share their story and inspiration behind their jersey through a custom content series featured on Rangers digital channels.

“When we expanded our partnership with Northwell Health four years ago, a core focus for each of us was making a positive impact on our communities and recognizing those who go above and beyond for people in need,” said Ron Skotarczak, executive vice president, marketing partnerships, Madison Square Garden Sports. “Despite all the challenging moments throughout 2020, we witnessed acts of heroism that show how strong New York truly is and we can’t wait to bring these stories to light through this platform.”

“We are honored to partner with The New York Rangers on this campaign as it provides another opportunity to put a spotlight on some of the bravest acts we’ve seen during this pandemic,” said Michael Dowling, president and CEO of Northwell Health. “These inspiring New Yorkers are the real winners this season so it’s only fair that their jerseys – and their stories – get time on the ice.”

NYRises focuses on highlighting New Yorkers who remind us to never stop, no matter how tough the situation. The Rangers and Northwell Health will honor hundreds of people throughout the season by providing custom practice jerseys, recognition on Rangers social channels and providing charitable donations on behalf of these incredible New Yorkers.

About Madison Square Garden Sports Corp

Madison Square Garden Sports Corp. (MSG Sports) is a leading professional sports company, with a collection of assets that includes: the New York Knicks (NBA) and the New York Rangers (NHL); two development league teams – the Westchester Knicks (NBAGL) and the Hartford Wolf Pack (AHL); and esports teams through Counter Logic Gaming, a leading North American esports organization, and Knicks Gaming, an NBA 2K League franchise. MSG Sports also operates two professional sports team performance centers – the MSG Training Center in Greenburgh, NY and the CLG Performance Center in Los Angeles, CA. More information is available at www.msgsports.com.

About Northwell Health

Northwell Health is New York State’s largest health care provider and private employer, with 23 hospitals, nearly 800 outpatient facilities and more than 14,200 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 74,000 employees – 18,500 nurses and 4,500 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We’re training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Twitter, Instagram and LinkedIn.

MEDIA:

Madison Square Garden Sports:

Ryan Watson

[email protected]

Northwell Health:

Joe Kemp

[email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Hockey Health Sports Hospitals General Health General Sports

MEDIA:

Photo
Photo
Northwell Health Becomes the New York Rangers’ First Practice Jersey Sponsor (Photo: MSG Sports)
Logo
Logo
Logo
Logo